Diabetes mellitus and Alzheimers disease;Diabetes és Alzheimer-kór

Orvosi Hetilap

Volumn 152, Issue 13, 2011, Pages 512-515

  Salacz, Pál ^a   Csibri, Éva ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Alzheimer's disease; cognitive; diabetes mellitus; insulin; risk; therapy

Indexed keywords

AGING; ALZHEIMER DISEASE; ARTICLE; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; DEGENERATIVE DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; HUMAN; INSULIN RESISTANCE; METABOLIC DISORDER; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK ASSESSMENT;

AGE FACTORS; ALZHEIMER DISEASE; COGNITION; COMORBIDITY; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; INCIDENCE; INSULIN RESISTANCE; POPULATION DYNAMICS; PUBLIC HEALTH; RISK ASSESSMENT; RISK FACTORS;

EID: 79952825738     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2011.29071     Document Type: Article

References (24)

1. Reitz, C., Tang, M. X., Schupf, N. és mtsai: A summary risk score for the prediction of Alzheimer disease in elderly persons. Arch. Neurol., 2010, 67 , 835-841.
2. Raina, P., Santaguida, P., Ismaila, A. és mtsai: Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline. Ann. Intern. Med., 2008, 148 , 379-397.
3. Atri, A., Shaughnessy, L. W., Locascio, J. J. és mtsa: Long-term course and effectiveness of combination therapy in Alzheimer disease. Alzheimer Dis. Assoc. Disord., 2008, 22 , 209-221.
4. Kovacs, T.: Therapy of Alzheimer disease. Neuropsychopharmacol. Hung., 2009, 11 , 27-33.
5. Ott, A., Stolk, R. P., Pols, H. A. és mtsai: Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology, 1999, 53 , 1937-1942.
6. Peila, R., Rodriguez, B. L., Launer, L. J.: Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes, 2002, 51 , 1256-1262.
7. Luchsinger, J. A., Tang, M. X., Stern, Y. és mtsai: Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am. J. Epidemiol., 2001, 154 , 635-641.
8. MacKnight, C., Rockwood, K., Awalt, E. és mtsa: Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging. Dement. Geriatr. Cogn. Disord., 2002, 14 , 77-83.
9. Hassing, L. B., Johansson, B., Nilsson, S. E. és mtsai: Diabetes mellitus is a risk factor for vascular dementia, but not for Alzheimer's disease: a population-based study of the oldest old. Int. Psychogeriatr., 2002, 14 , 239-248.
10. Profenno, L. A., Porsteinsson, A. P., Faraone, S. V.: Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders. Biol. Psychiatry, 2010, 67 , 505-512.
11. Arvanitakis, Z., Wilson, R. S., Bienias, J. L. és mtsai: Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch. Neurol., 2004, 61 , 661-666.
12. Helzner, E. P., Scarmeas, N., Cosentino, S. és mtsai: Survival in Alzheimer disease: a multiethnic, population-based study of incident cases. Neurology, 2008, 71 , 1489-1495.
13. Ahtiluoto, S., Polvikoski, T., Peltonen, M. és mtsai: Diabetes, Alzheimer disease, and vascular dementia: a population-based neuropathologic study. Neurology, 2010, 75 , 1195-1202.
14. Messier, C., Gagnon, M.: Cognitive decline associated with dementia and type 2 diabetes: the interplay of risk factors. Diabetologia, 2009, 52 , 2471-2474.
15. Xu, W. L., Qiu, C. X., Winblad, B. és mtsai: Uncontrolled diabetes increases the risk of Alzheimer's disease: a population-based cohort study. Diabetologia, 2009, 52 , 1031-1039.
16. Benedict, C., Hallschmid, M., Schmitz, K. és mtsai: Intranasal insulin improves memory in humans: superiority of insulin aspart. Neuropsychopharmacology, 2007, 32 , 239-243.
17. Gold, S. M., Dziobek, I., Sweat, V. és mtsai: Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes. Diabetologia, 2007, 50 , 711-719.
18. Halmos T., Suba I.: Az agy szerepe az anyagcsere és energiaforgalom szabályozásában: az inzulin központi idegrendszeri hatásai, az agy inzulinrezisztenciája. Orv. Hetil., 2011, 152 , 83-91.
19. Craft, S.: Insulin resistance syndrome and Alzheimer disease: pathophysiologic mechanisms and therapeutic implications. Alzheimer Dis. Assoc. Disord., 2006, 20 , 298-301.
20. Jiang, Q., Heneka, M., Landreth, G. E.: The role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in Alzheimer's disease: therapeutic implications. CNS Drugs, 2008, 22 , 1-14.
21. Risner, M. E., Saunders, A. M., Altman, J. F. és mtsai: Efficacy of rosiglitazone in a genetically defined population with mild-tomoderate Alzheimer's disease. Pharmacogenomics J., 2006, 6 , 246-254.
22. McClean, P. L., Gault, V. A., Harriott, P. és mtsa: Glucagon-like peptide-1 analogues enhance synaptic plasticity in the brain: a link between diabetes and Alzheimer's disease. Eur. J. Pharmacol., 2010, 630 , 158-162.
23. Zhong, Y., Li, S. H., Liu, S. M. és mtsai: Reactive protein upregulates receptor for advanced glycation end products expression in human endothelial cells. Hypertension, 2006, 48 , 504-511.
24. Valente, T., Gella, A., Fernandez-Busquets, X. és mtsai: Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer's disease and diabetes mellitus. Neurobiol. Dis., 2010, 37 , 67-76.